Metabolic Compounds – Research Overview

A focused directory of compounds studied for metabolic function, weight management, fat loss, and exercise mimicry. Each entry links to its full in-depth research overview.

Disclaimer This overview is strictly educational and based on publicly available scientific literature and regulatory information as of April 2026. It does not constitute medical advice, endorsement, or encouragement of use. Always consult a qualified healthcare professional and comply with all applicable laws and regulations.

GLP-1 & Weight Management Peptides

  1. Cagrilintide – Long-acting amylin analog for appetite control and weight loss. See also: Semaglutide, Retatrutide.
  2. Retatrutide – Triple agonist (GLP-1/GIP/Glucagon) with powerful weight-loss data. See also: Tirzepatide, Semaglutide.
  3. Semaglutide – GLP-1 receptor agonist used for diabetes and chronic weight management. See also: Tirzepatide, Retatrutide.
  4. Tirzepatide (Tirz) – Dual GIP/GLP-1 agonist with strong efficacy in obesity and T2D. See also: Semaglutide, Retatrutide.
  5. Tesofensine – Triple monoamine reuptake inhibitor researched for appetite suppression. See also: Semaglutide.
  6. AOD-9604 – hGH fragment studied for lipolysis and fat metabolism. See also: Tesamorelin.

Exercise Mimetics & Metabolic Reprogramming

  1. 5-Amino-1MQ – NNMT inhibitor for metabolic reprogramming and fat loss. See also: BAM15, SLU-PP-332.
  2. BAM15 – Mitochondrial uncoupler researched as an exercise mimetic. See also: SLU-PP-332, 5-Amino-1MQ.
  3. SLU-PP-332 – ERR pan-agonist and exercise mimetic. See also: BAM15, MOTS-c.
  4. MOTS-c – Mitochondrial-derived peptide with metabolic and exercise-like effects. See also: SLU-PP-332, BAM15.